AI Insight: Agilysys is currently trading 36% below a high-confidence fair value estimate, suggesting potential undervaluation supported by a strong DCF mid-range of $204.08. Financial health is good with low leverage and solid growth, though Monte Carlo volatility and a 37.5% downside risk highlight substantial investment risk. Valuation metrics indicate opportunity tempered by high scenario outcome variability.